PHARMAGEN, INC. Debt Conversion, Converted Instrument, Amount
PHARMAGEN, INC. reported Debt Conversion, Converted Instrument, Amount of $1.29 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2013-11-14
- PHARMAGEN, INC. debt conversion, converted instrument, amount for the quarter ending 2013-09-30 was $699.95K.
- PHARMAGEN, INC. debt conversion, converted instrument, amount for the quarter ending 2013-06-30 was $79.31K.
- PHARMAGEN, INC. debt conversion, converted instrument, amount for the quarter ending 2013-03-31 was $511.55K.
- PHARMAGEN, INC. debt conversion, converted instrument, amount for the quarter ending 2012-12-31 was $879.18K.
- PHARMAGEN, INC. debt conversion, converted instrument, amount for fiscal 2012 was $2.07M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2013-09-30 | $699.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $779.26K derived: sum of 2 quarters · filed 2013-11-14 | $1.29M 10-Q · filed 2013-11-14 | $2.17M derived: sum of 4 quarters · filed 2013-11-14 |
| 2013-06-30 | $79.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $590.86K 10-Q · filed 2013-08-14 | $1.47M derived: sum of 3 quarters · filed 2013-08-14 | $1.47M derived: sum of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | $511.55K 10-Q · filed 2013-05-15 | $1.39M derived: sum of 2 quarters · filed 2013-05-15 | $1.39M derived: sum of 3 quarters · filed 2013-05-15 | |
| 2012-12-31 | $879.18K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $879.18K derived: sum of 2 quarters · filed 2013-04-01 | $2.07M 10-K · filed 2013-04-01 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $1.19M 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $1.19M 10-Q/A · filed 2012-09-14 | |||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-14 |